1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Autoimmune Drug Focus MARCH 2016

Autoimmune Drug Focus MARCH 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Merck KGaA Trial Highlights Growing Potential Biosimilar Adalimumab Market
Industry Trend Analysis - Collaboration Holds Potential To Stem Declining Diabetes Sales
Industry Brief - Biocon Enters Insulin Agreement With Lab PiSA
Industry Brief - FDA Accepts Allergan's Rifaximin ANDA For Filing
Industry Trend Analysis - Lupin On Course To Cement Place In US Market
Industry Brief - TiGenix Submits EU MAA For Cx601
Industry Brief - TiGenix' Cx601 Shows Promising Results In Phase III Admire-CD Trial
Industry Brief - Tofacitinib Yields Promising Results In Pivotal Phase III OCTAVE Trials
Industry Brief - Opexa Initiates Restructuring To Focus Use Of Resources
Industry Trend Analysis - Narrowing Trials Reduces Expenditure But Increases Risks For Arzerra
Industry Brief - MHLW Lifts All-Case Surveillance Condition For Humira Approval
Industry Brief - MTP/Janssen Amend Simponi Marketing Agreement
Industry Brief - Sarilumab Superior Over Adalimumab In Phase III Active RA Study
Industry Brief - Can-Fite Submits CF101 Phase III Protocol Design To EMA For Treating RA
Industry Brief - CHMP Recommends Ixekizumab To Treat Moderate-to-Severe Plaque Psoriasis
Industry Trend Analysis - AstraZeneca/Boehringer Ingelheim Tie Will Create Strong Development/Marketing Platform
Industry Brief - FDA Accepts Amgen's sBLA For Expanded Use Of Enbrel
Industry Brief - Scientific Approval For LEO Pharma's Enstilar To Treat Psoriasis In EU
Industry Brief - EMA ODD For TNT009 To Treat Cold Agglutinin Disease
Industry Brief - Fostamatinib Phase II Trial Initiated In AIHA
Industry Trend Analysis - Diagnostic Advances To Unlock New SLE Treatment Avenues
Industry Brief - FDA Fast Track Designation For Aurinia's Voclosporin For LN
Industry Brief - GSK Reports Publication Of Benlysta Long-Term Analysis In SLE
Industry Brief - Corbus Initiates Resunab Phase II Trial In SLE
Industry Brief - FDA ODD For AstraZeneca's MEDI-551 To Treat NMO/NMOSD
Industry Brief - First Patients Dosed In Xencor's XmAb5871 Phase II IgG4-RD/SLE Trials
Industry Brief - Evotec Earns Preclinical Milestone In Collaboration With Padlock
Industry Brief - Chugai Secures Japanese ODD For Tocilizumab To Treat Systemic Scleroderma
Industry Brief - hCDR1 Phase II Trial Design Completed In SLE
Industry Brief - ImmunogenX Completes Alvine's Non-Cash Assets Takeover
Industry Brief - Autoimmune Conferences - June 2016

Table Of Contents

Autoimmune Drug Focus MARCH 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.